Return on Assets (ROA)
since 2005
Calculation
Abiomed Inc., ROA, long-term trends, calculation
| ROA | = | 100 | × | Net income (loss)1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | 8.16% | = | 100 | × | 136,505) | ÷ | 1,673,393) |
| Mar 31, 2021 | 15.09% | = | 100 | × | 225,525) | ÷ | 1,494,359) |
| Mar 31, 2020 | 16.69% | = | 100 | × | 203,009) | ÷ | 1,216,462) |
| Mar 31, 2019 | 24.57% | = | 100 | × | 259,016) | ÷ | 1,054,346) |
| Mar 31, 2018 | 14.26% | = | 100 | × | 112,170) | ÷ | 786,375) |
| Mar 31, 2017 | 9.47% | = | 100 | × | 52,116) | ÷ | 550,414) |
| Mar 31, 2016 | 9.00% | = | 100 | × | 38,147) | ÷ | 423,931) |
| Mar 31, 2015 | 33.60% | = | 100 | × | 113,688) | ÷ | 338,367) |
| Mar 31, 2014 | 3.58% | = | 100 | × | 7,351) | ÷ | 205,407) |
| Mar 31, 2013 | 8.83% | = | 100 | × | 15,014) | ÷ | 169,999) |
| Mar 31, 2012 | 0.97% | = | 100 | × | 1,495) | ÷ | 153,911) |
| Mar 31, 2011 | -8.93% | = | 100 | × | (11,755) | ÷ | 131,588) |
| Mar 31, 2010 | -14.68% | = | 100 | × | (19,024) | ÷ | 129,570) |
| Mar 31, 2009 | -23.24% | = | 100 | × | (31,597) | ÷ | 135,958) |
| Mar 31, 2008 | -34.68% | = | 100 | × | (40,930) | ÷ | 118,031) |
| Mar 31, 2007 | -20.47% | = | 100 | × | (27,881) | ÷ | 136,183) |
| Mar 31, 2006 | -37.50% | = | 100 | × | (29,449) | ÷ | 78,537) |
| Mar 31, 2005 | -3.84% | = | 100 | × | (2,342) | ÷ | 61,061) |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1 US$ in thousands
The financial trajectory from 2005 to 2022 reveals a distinct transition from a period of sustained operational losses and negative asset productivity to a phase of high profitability, followed by a recent trend of normalizing returns as the asset base expanded.
- Initial Period of Negative Returns (2005–2011)
- Between 2005 and 2011, a consistent pattern of negative net income was observed, resulting in negative Return on Assets (ROA). The most significant contraction in asset productivity occurred in 2006 and 2008, with ROA reaching lows of -37.50% and -34.68%, respectively. However, a gradual recovery trend began after 2008, as net losses narrowed from -40.93 million in 2008 to -11.76 million by 2011, leading to a corresponding improvement in ROA from -34.68% to -8.93%.
- Transition to Profitability and Peak Efficiency (2012–2019)
- A pivotal shift occurred in 2012, marking the first instance of positive net income and a positive ROA of 0.97%. This momentum accelerated significantly through 2015, where ROA spiked to 33.60%, the highest recorded value in the period. While ROA fluctuated between 2016 and 2017, a strong upward trend resumed in 2018 and 2019, peaking at 24.57% in 2019. This period was characterized by substantial growth in net income, which rose from 1.50 million in 2012 to 259.02 million in 2019.
- Asset Expansion and Return Normalization (2020–2022)
- From 2020 onward, a divergence is observed between total asset growth and ROA. While total assets continued to scale rapidly—increasing from 1.05 billion in 2019 to 1.67 billion in 2022—the ROA exhibited a steady decline. The ROA decreased from its 2019 peak of 24.57% to 16.69% in 2020, 15.09% in 2021, and finally to 8.16% in 2022. This suggests that while the organization continued to grow its asset base, the rate of net income growth did not keep pace with the expansion of assets, leading to a reduction in overall asset utilization efficiency.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
Abiomed Inc., ROA, long-term trends, comparison to competitors
| Abiomed Inc. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Mar 31, 2022 | 8.16% | 9.31% | 5.86% | 10.19% | 5.54% | 8.19% |
| Mar 31, 2021 | 15.09% | 9.40% | 6.26% | 12.58% | 3.87% | 8.15% |
| Mar 31, 2020 | 16.69% | 6.20% | 5.28% | 9.50% | 5.28% | 7.81% |
| Mar 31, 2019 | 24.57% | 5.43% | 6.21% | 14.17% | 5.16% | 7.96% |
| Mar 31, 2018 | 14.26% | 3.53% | 5.24% | 14.37% | 3.40% | 7.87% |
| Mar 31, 2017 | 9.47% | 0.63% | 5.45% | 11.46% | 4.04% | 7.59% |
| Mar 31, 2016 | 9.00% | 2.66% | 3.79% | 11.34% | 3.55% | 5.71% |
| Mar 31, 2015 | 33.60% | 10.72% | 4.15% | 12.00% | 2.51% | 5.22% |
| Mar 31, 2014 | 3.58% | 5.53% | 4.14% | 10.58% | 8.08% | 6.50% |
| Mar 31, 2013 | 8.83% | 6.00% | 4.18% | 16.99% | 9.95% | 6.87% |
| Mar 31, 2012 | 0.97% | 8.87% | 4.50% | 16.18% | 10.93% | 6.83% |
| Mar 31, 2011 | -8.93% | 7.84% | 5.09% | 16.16% | 10.18% | 7.57% |
| Mar 31, 2010 | -14.68% | 7.78% | 5.75% | 15.97% | 11.03% | 7.35% |
| Mar 31, 2009 | -23.24% | 10.96% | 9.10% | 12.85% | 9.17% | 6.47% |
| Mar 31, 2008 | -34.68% | 11.51% | 5.15% | 13.86% | 10.05% | 5.33% |
| Mar 31, 2007 | -20.47% | 9.08% | 6.43% | 13.90% | 14.36% | 9.14% |
| Mar 31, 2006 | -37.50% | 4.75% | 5.98% | 10.72% | 12.95% | 8.61% |
| Mar 31, 2005 | -3.84% | 11.57% | 4.79% | 18.77% | 10.86% | 7.98% |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Sector (Health Care Equipment & Services)
Abiomed Inc., ROA, long-term trends, comparison to sector (health care equipment & services)
| Abiomed Inc. | Health Care Equipment & Services | |
|---|---|---|
| Mar 31, 2022 | 8.16% | 7.49% |
| Mar 31, 2021 | 15.09% | 7.28% |
| Mar 31, 2020 | 16.69% | 6.62% |
| Mar 31, 2019 | 24.57% | 6.77% |
| Mar 31, 2018 | 14.26% | 5.72% |
| Mar 31, 2017 | 9.47% | 5.00% |
| Mar 31, 2016 | 9.00% | 4.37% |
| Mar 31, 2015 | 33.60% | 4.93% |
| Mar 31, 2014 | 3.58% | 6.03% |
| Mar 31, 2013 | 8.83% | 6.64% |
| Mar 31, 2012 | 0.97% | 7.54% |
| Mar 31, 2011 | -8.93% | 7.54% |
| Mar 31, 2010 | -14.68% | 7.69% |
| Mar 31, 2009 | -23.24% | 8.84% |
| Mar 31, 2008 | -34.68% | 7.51% |
| Mar 31, 2007 | -20.47% | 8.92% |
| Mar 31, 2006 | -37.50% | 7.40% |
| Mar 31, 2005 | -3.84% | 7.94% |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Industry (Health Care)
Abiomed Inc., ROA, long-term trends, comparison to industry (health care)
| Abiomed Inc. | Health Care | |
|---|---|---|
| Mar 31, 2022 | 8.16% | 9.66% |
| Mar 31, 2021 | 15.09% | 9.46% |
| Mar 31, 2020 | 16.69% | 5.81% |
| Mar 31, 2019 | 24.57% | 8.32% |
| Mar 31, 2018 | 14.26% | 7.90% |
| Mar 31, 2017 | 9.47% | 5.19% |
| Mar 31, 2016 | 9.00% | 7.31% |
| Mar 31, 2015 | 33.60% | 7.71% |
| Mar 31, 2014 | 3.58% | 8.59% |
| Mar 31, 2013 | 8.83% | 8.76% |
| Mar 31, 2012 | 0.97% | 8.09% |
| Mar 31, 2011 | -8.93% | 7.36% |
| Mar 31, 2010 | -14.68% | 7.24% |
| Mar 31, 2009 | -23.24% | 9.73% |
| Mar 31, 2008 | -34.68% | 9.50% |
| Mar 31, 2007 | -20.47% | 8.88% |
| Mar 31, 2006 | -37.50% | 10.52% |
| Mar 31, 2005 | -3.84% | 9.67% |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).